# Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients

> **NCT01780467** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **BEHAVIORAL:** Role of dopamine

## Key facts

- **NCT ID:** NCT01780467
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01780467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01780467, "Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01780467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*